Trials / Recruiting
RecruitingNCT06702111
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation
Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Adults: Clinical Outcome and Complications
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- The University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.
Conditions
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2029-12-01
- Completion
- 2030-12-01
- First posted
- 2024-11-22
- Last updated
- 2024-11-27
Locations
2 sites across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT06702111. Inclusion in this directory is not an endorsement.